CLDI — CALIDI BIOTHERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 24 SEC-registered investment managers reported holding CLDI (CALIDI BIOTHERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $108.82K across 640.10K shares. That is +23.9% by share count (+83.15K shares) versus the previous quarter, while reported value moved -11.8%. Ownership is concentrated: the five largest holders account for 64.3% of reported value and the top ten for 88.7%.
Compared with the prior quarter, 5 opened new positions, 7 added to existing stakes, 9 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of CALIDI BIOTHERAPEUTICS INC (CLDI) include D. E. Shaw & Co, Deutsche Bank AG, ARMISTICE CAPITAL, LLC, ranked by reported 13F value among the 83 institutional holders on this page.
CLDI is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 14 | 89.62K | $97.22K | -63.2% |
| Q2 2026 | 24 | 640.10K | $108.82K | +23.9% |
| Q1 2026 | 28 | 2.01M | $478.79K | +40.2% |
| Q4 2025 | 26 | 300.56K | $351.80K | +23.3% |
| Q3 2025 | 22 | 211.55K | $321.69K | -83.5% |
| Q2 2025 | 34 | 2.85M | $653.82K | -49.3% |
| Q1 2025 | 36 | 5.46M | $3.09M | +104.4% |
| Q4 2024 | 33 | 1.23M | $1.41M | +94.4% |
Over the 8 quarters shown, institutional share counts decreased 93% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (+104.4%).
Top Institutional Holders (Q3 2026) — 14 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 38.19K | $40.86K | 0.00% | Add | |
| 35.20K | $37.66K | 0.00% | Reduce | |
| 11.31K | $13.43K | 0.00% | New | |
| 2.22K | $2.38K | 0.00% | Reduce | |
| 1.59K | $1.71K | 0.00% | Reduce | |
| 625 | $669 | 0.00% | Reduce | |
| 217 | $232 | 0.00% | Reduce | |
| 172 | $184 | 0.00% | Reduce | |
| 66 | $71 | 0.00% | Reduce | |
| 12 | $13 | 0.00% | Reduce | |
| 6 | $7 | 0.00% | Reduce | |
| 3 | $3 | 0.00% | New | |
| 2 | $2 | 0.00% | New | |
| 1 | $2 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 24 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 114.55K | $19.47K | 0.00% | New | |
| 114.55K | $19.47K | 0.00% | Add | |
| 83.52K | $14.20K | 0.00% | Hold | |
| 54.27K | $9.23K | 0.00% | Add | |
| 45.00K | $7.65K | 0.00% | New | |
| 43.24K | $7.35K | 0.00% | Add | |
| 37.34K | $6.35K | 0.00% | Hold | |
| 30.00K | $5.10K | 0.00% | New | |
| 25.51K | $4.34K | 0.00% | Hold | |
| 19.92K | $3.39K | 0.00% | Hold | |
| 17.76K | $3.02K | 0.00% | Hold | |
| 13.24K | $2.25K | 0.00% | Add | |
| 12.00K | $2.04K | 0.00% | New | |
| 10.00K | $1.70K | 0.00% | Hold | |
| 7.88K | $1.34K | 0.00% | New | |
| 4.59K | $781 | 0.00% | Add | |
| 2.65K | $450 | 0.00% | Add | |
| 1.40K | $237 | 0.00% | Hold | |
| 1.04K | $177 | 0.00% | Hold | |
| 1.04K | $177 | 0.00% | Hold | |
| 375 | $64 | 0.00% | Add | |
| 101 | $18 | 0.00% | Hold | |
| 100 | $17 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 879.00K | $209.91K | 0.00% | New | |
| 434.90K | $103.86K | 1.21% | New | |
| 250.00K | $59.48K | 0.03% | New | |
| 83.52K | $19.95K | 0.00% | Hold | |
| 75.77K | $18.00K | 0.00% | Add | |
| 63.02K | $15.05K | 0.00% | Add | |
| 40.26K | $9.61K | 0.00% | Add | |
| 37.34K | $8.92K | 0.00% | New | |
| 34.80K | $8.31K | 0.00% | Add | |
| 25.51K | $6.10K | 0.00% | New | |
| 19.92K | $4.76K | 0.00% | Hold | |
| 17.76K | $4.24K | 0.00% | Hold | |
| 10.00K | $2.43K | 0.00% | Hold | |
| 9.47K | $2.26K | 0.00% | Add | |
| 9.22K | $2.20K | 0.00% | New | |
| 10.13K | $2.00K | 0.00% | New | |
| 2.11K | $503 | 0.00% | Hold | |
| 1.40K | $333 | 0.00% | Reduce | |
| 1.04K | $249 | 0.00% | Hold | |
| 1.04K | $249 | 0.00% | Hold | |
| 1.04K | $248 | 0.00% | Hold | |
| 255 | $61 | 0.00% | Reduce | |
| 115 | $27 | 0.00% | Add | |
| 101 | $25 | 0.00% | Hold | |
| 100 | $24 | 0.00% | Hold |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 83.52K | $97.72K | 0.00% | Reduce | |
| 41.93K | $49.06K | 0.00% | Add | |
| 34.73K | $40.63K | 0.00% | Hold | |
| 22.01K | $25.75K | 0.00% | Add | |
| 21.24K | $25.00K | 0.00% | New | |
| 20.26K | $23.70K | 0.01% | Add | |
| 19.97K | $23.37K | 0.00% | Reduce | |
| 17.76K | $20.78K | 0.00% | New | |
| 11.49K | $13.44K | 0.00% | New | |
| 10.00K | $11.70K | 0.00% | New | |
| 7.51K | $8.79K | 0.00% | Add | |
| 2.77K | $3.25K | 0.00% | New | |
| 2.11K | $2.46K | 0.00% | Add | |
| 1.47K | $1.72K | 0.00% | Add | |
| 1.04K | $1.22K | 0.00% | Hold | |
| 1.04K | $1.22K | 0.00% | Hold | |
| 1.04K | $1.22K | 0.00% | Hold | |
| 292 | $342 | 0.00% | Hold | |
| 101 | $119 | 0.00% | Hold | |
| 100 | $117 | 0.00% | Hold | |
| 46 | $54 | 0.00% | Hold | |
| 46 | $53 | 0.00% | Add | |
| 42 | $49 | 0.00% | Hold | |
| 28 | $33 | 0.00% | New | |
| 1 | $2 | 0.00% | Hold |
Q3 2025 — 22 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 84.96K | $129.13K | 0.00% | Reduce | |
| 34.73K | $52.79K | 0.00% | Reduce | |
| 29.59K | $44.98K | 0.00% | Reduce | |
| 20.82K | $31.65K | 0.00% | Reduce | |
| 18.70K | $28.43K | 0.01% | New | |
| 15.26K | $23.19K | 0.01% | New | |
| 2.56K | $3.90K | 0.00% | Reduce | |
| 1.04K | $1.58K | 0.00% | Reduce | |
| 1.04K | $1.58K | 0.00% | New | |
| 1.04K | $1.58K | 0.00% | Reduce | |
| 417 | $1.00K | 0.00% | Reduce | |
| 387 | $588 | 0.00% | Reduce | |
| 292 | $444 | 0.00% | Reduce | |
| 125 | $190 | 0.00% | New | |
| 101 | $154 | 0.00% | Reduce | |
| 100 | $152 | 0.00% | New | |
| 253 | $149 | 0.00% | Reduce | |
| 46 | $70 | 0.00% | Reduce | |
| 42 | $64 | 0.00% | Reduce | |
| 30 | $46 | 0.00% | Reduce | |
| 9 | $14 | 0.00% | Reduce | |
| 1 | $2 | 0.00% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 792.00K | $182.16K | 0.00% | Reduce | |
| 422.50K | $97.17K | 0.00% | Reduce | |
| 353.38K | $81.28K | 0.00% | Hold | |
| 249.83K | $57.46K | 0.00% | Hold | |
| 232.58K | $53.49K | 0.00% | Reduce | |
| 119.47K | $27.48K | 0.00% | Hold | |
| 101.00K | $23.23K | 0.02% | Hold | |
| 80.83K | $18.59K | 0.01% | Hold | |
| 71.20K | $16.38K | 0.00% | New | |
| 61.29K | $14.10K | 0.00% | Hold | |
| 48.69K | $11.20K | 0.00% | Hold | |
| 45.00K | $10.35K | 0.00% | Reduce | |
| 44.90K | $10.33K | 0.00% | Add | |
| 43.61K | $10.00K | 0.00% | New | |
| 31.10K | $7.15K | 0.00% | New | |
| 26.75K | $6.15K | 0.00% | Add | |
| 21.02K | $4.83K | 0.00% | Hold | |
| 13.21K | $3.04K | 0.00% | New | |
| 13.50K | $3.00K | 0.00% | Hold | |
| 12.50K | $2.88K | 0.00% | Hold | |
| 12.50K | $2.88K | 0.00% | Hold | |
| 10.00K | $2.30K | 0.00% | Hold | |
| 8.94K | $2.06K | 0.00% | Add | |
| 10.24K | $2.00K | 0.00% | Reduce | |
| 6.34K | $1.46K | 0.00% | Hold |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 114.55K sh · $19.47K
- Independent Advisor Alliance 45.00K sh · $7.65K
- Private Advisor Group, LLC 30.00K sh · $5.10K
- RFG Advisory, LLC 12.00K sh · $2.04K
- UBS Group AG 7.88K sh · $1.34K
Fully Exited (vs previous quarter)
- ARMISTICE CAPITAL, LLC sold 879.00K sh · $209.91K
- SABBY MANAGEMENT, LLC sold 434.90K sh · $103.86K
- Warberg Asset Management LLC sold 250.00K sh · $59.48K
- Virtu Financial LLC sold 75.77K sh · $18.00K
- VANGUARD FIDUCIARY TRUST CO sold 9.22K sh · $2.20K
- HRT FINANCIAL LP sold 10.13K sh · $2.00K
- Apollo Management Holdings, L.P. sold 1.04K sh · $249
- Fidelity Management & Research (FMR) sold 255 sh · $61
- CVA Family Office, LLC sold 42 sh · $10
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UBS Group AG | 38.19K | 7.88K | — | 7.51K | 2.56K | 44.90K | 1 | 8.80K | 922 | 10 | 10 | 10 | 10 | 10 | 11 | 24 | — | 1.59K | 1.55K | 7.42K |
| Geode Capital Management | 35.20K | 114.55K | 63.02K | 41.93K | 29.59K | 232.58K | 251.92K | 160.02K | 39.61K | — | 107.11K | 102.24K | — | — | — | — | — | — | — | — |
| StoneX Group Inc. | 11.31K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Arax Advisory Partners | 2.22K | 37.34K | 37.34K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.59K | 25.51K | 25.51K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Farther Finance Advisors, LLC | 625 | 10.00K | 10.00K | 10.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SBI Securities Co., Ltd. | 217 | 375 | 115 | 46 | 46 | 560 | 300 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OSAIC HOLDINGS, INC. | 172 | 2.65K | 2.11K | 2.11K | 253 | 26.75K | 19.25K | 753 | 253 | 2.52K | 2.52K | — | — | — | — | — | — | — | — | — |
| Finepoint Capital LP | 66 | 1.04K | 1.04K | 1.04K | 1.04K | 12.50K | 12.50K | 12.50K | 12.50K | 125.00K | 125.00K | 125.00K | 125.00K | — | — | — | — | — | — | — |
| Morgan Stanley | 12 | 13.24K | 9.47K | 1.47K | 387 | 1.92K | 2.02K | 2.52K | 2.02K | 19.19K | 19.19K | 19.19K | — | — | — | — | — | — | — | — |
| Tradewinds Capital Management, LLC | 6 | 101 | 101 | 101 | 101 | 1.00K | 1.00K | 1.00K | — | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 3 | — | 255 | 22.01K | 125 | — | — | — | 141 | — | — | — | — | — | — | — | — | — | — | — |
| EVERMAY WEALTH MANAGEMENT LLC | 1 | 1 | 1 | 1 | 1 | 6.34K | 6.34K | 6.34K | 6.34K | — | 63.42K | — | — | — | — | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 2 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ARMISTICE CAPITAL, LLC | — | — | 879.00K | — | — | 792.00K | 3.32M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| METEORA CAPITAL, LLC | — | — | — | — | — | — | — | — | — | — | 249.81K | 288.83K | 433.72K | — | — | — | — | — | — | — |
| Cable Car Capital, LP | — | — | — | — | — | — | — | — | 82.94K | 11.28K | 472.76K | 538.86K | — | — | — | — | — | — | — | — |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | — | 1.04K | 1.04K | 1.04K | 1.04K | 12.50K | 12.50K | 12.50K | 6.25K | 62.50K | — | — | 125.00K | — | — | — | — | — | — | — |
| Red Wave Investments LLC | — | — | — | — | — | 80.83K | 80.83K | 80.83K | 46.46K | 624.60K | 644.60K | 56.55K | 56.55K | — | — | — | — | — | — | — |
| DRIEHAUS CAPITAL MANAGEMENT LLC | — | — | — | — | — | — | — | — | — | 94.70K | 94.70K | 94.70K | 94.70K | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold CLDI?
As of 2026-Q2, 24 institutional funds reported holding CLDI (CALIDI BIOTHERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $108.82K.
How many shares of CLDI do institutions own?
13F filers reported 640.10K shares of CLDI, worth $108.82K in aggregate at the end of 2026-Q2.
Is institutional ownership of CLDI rising or falling?
Share counts moved +23.9% versus the prior quarter — accumulation.
Who are the top institutional holders of CLDI?
The largest 13F holders are D. E. Shaw & Co, Deutsche Bank AG, ARMISTICE CAPITAL, LLC, MILLENNIUM MANAGEMENT LLC, Millennium Management; the top 25 are ranked at the top of this page.
Who are the major shareholders of CALIDI BIOTHERAPEUTICS INC?
The major shareholders of CALIDI BIOTHERAPEUTICS INC (CLDI) by reported 13F value are D. E. Shaw & Co, Deutsche Bank AG, ARMISTICE CAPITAL, LLC, MILLENNIUM MANAGEMENT LLC, Millennium Management, among 83 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.